# Putnam BioRevolution ETF (SYNB): ETF Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/synb for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Franklin Templeton · Asset class: Equity - Strategy: Thematic · Inception: 2022-09-29 The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified. ## Key Facts | Metric | Value | |---|---| | Price | $31.61 | | Expense Ratio | 0.70% | | Assets Under Management | $1.6M | | NAV | $31.59 | | Holdings Count | 38 | | Distribution Yield (TTM) | — | | Annual Distribution (TTM) | — /share | | Distribution Frequency | Annual | | 52-Week Range | $24.57 – $31.73 | | Beta | 1.07 | ## Latest Distribution - Amount: $0.2139 /share - Ex-date: 2024-12-05 - Pay date: 2024-12-09 ## Frequently Asked Questions ### What does SYNB invest in? The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified. ### What is the expense ratio of SYNB? Putnam BioRevolution ETF (SYNB) charges an expense ratio of 0.70%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is SYNB? Putnam BioRevolution ETF (SYNB) manages $1.6M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is SYNB actively managed or an index fund? SYNB's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy. ### When was SYNB launched? Putnam BioRevolution ETF (SYNB) launched in September 2022 and is managed by Franklin Templeton. ### How has SYNB performed? SYNB's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does SYNB pay a dividend? Putnam BioRevolution ETF (SYNB) currently distributes little or no income. Trailing-twelve-month yield is —. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does SYNB pay dividends? Putnam BioRevolution ETF pays dividends Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is SYNB's dividend yield? SYNB's trailing-twelve-month yield is —, calculated from the sum of dividends over the past year divided by the current price. ### When is SYNB's next ex-dividend date? The most recently announced ex-dividend date for SYNB was 2024-12-05. The next ex-date typically follows Annual; once announced it appears at the top of the dividend history table on this page. ### How much will SYNB's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.70% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does SYNB charge its expense ratio? The expense ratio is deducted in tiny daily slices from SYNB's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does SYNB cost more than a fund like VOO? SYNB's strategy (current expense ratio 0.70%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where SYNB sits within its own category, which is the comparison that actually matters. ### Are there cheaper alternatives to SYNB? The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as SYNB (0.70%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/synb - Distribution history: https://www.dividenddata.com/funds/synb/dividend - Holdings & diversification: https://www.dividenddata.com/funds/synb/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/synb/expenses - Peer comparison: https://www.dividenddata.com/funds/synb/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.